Funding Opportunities and Sponsor News

Displaying Results: [21 - 30] of 1618

Hold the Control button (Ctrl) to click on multiple disciplines
Title Posted Disciplines Next Upcoming Internal Deadline Next Upcoming External Deadline
Weston Brain Institute:Early Phase Clinical Trials: Canada

The Early Phase Clinical Trials program provides funding to support translational research that accelerates the development of therapeutics for neurodegenerative disease aging.

3 years 7 months ago
  • Health and Life Sciences
Weston Brain Institute: Transformational Research: Canada 2019 (Parkinson's & Related Diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ...

2 years 7 months ago
  • Health and Life Sciences
Weston Brain Institute: Transformational Research: Canada 2019 (Alzheimer’s & Related Diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ...

2 years 7 months ago
  • Health and Life Sciences
Weston Brain Institute: Transformational Research - Canada 2020 (Parkinson's and related diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ...

1 year 5 months ago
  • Health and Life Sciences
Weston Brain Institute: Transformational Research - Canada 2020 (Alzheimer's and related diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ...

1 year 5 months ago
  • Health and Life Sciences
Weston Brain Institute: Rapid Response: Canada 2019 (Parkinson's & Related Diseases)

Seed Funding for novel, high-risk, high-reward translational research on neurodegenerative diseases of aging. Preliminary data is not required. 

New for 2018/19:

  • Certain complementary approaches (i.e., diet, physical activity, sleep and...
3 years 4 months ago
  • Health and Life Sciences
  • Information and Communications Technology
  • Physical Sciences and Engineering
Weston Brain Institute: Rapid Response: Canada 2018 (Alzheimer’s and Related Diseases)

Seed funding for novel, high-risk, high-reward translational research on neurodegenerative diseases of aging

3 years 7 months ago
  • Health and Life Sciences
Weston Brain Institute: Rapid Response - Canada 2020 (Parkinson's and related diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. 

...
1 year 5 months ago
  • Health and Life Sciences
Weston Brain Institute: Rapid Response - Canada 2020 (Alzheimer's and related diseases)

Neurodegenerative diseases of aging are among the least understood and most under treated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. 

...
1 year 5 months ago
  • Health and Life Sciences
Weston Brain Institute: Rapid Response - Canada 2019 (Parkinson's and Related Diseases)

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The Rapid...

2 years 7 months ago
  • Health and Life Sciences